Ivana Vancurova Selected Research

Ivana Vancurova Research Topics

Disease

24	Neoplasms (Cancer) 01/2022 - 11/2005
14	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 01/2014
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2014
6	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2014
6	Inflammation (Inflammations) 12/2016 - 09/2003
4	Bronchopulmonary Dysplasia 04/2009 - 08/2002
3	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2015 - 01/2014
3	Multiple Myeloma 01/2014 - 01/2014
2	Triple Negative Breast Neoplasms 01/2020 - 01/2018
2	Carcinogenesis 10/2018 - 01/2014
2	Infections 03/2015 - 11/2014
2	Leukemia 01/2014 - 01/2012
2	Prostatic Neoplasms (Prostate Cancer) 09/2013 - 07/2008
2	Sepsis (Septicemia) 03/2007 - 11/2005
1	Genomic Instability 11/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2018
1	Ovarian Epithelial Carcinoma 01/2017
1	Premature Birth (Birth, Premature) 12/2016
1	fetal inflammatory response syndrome 04/2009
1	Acute Lung Injury 03/2007
1	Arthritis (Polyarthritis) 12/2006
1	Septic Shock (Toxic Shock Syndrome) 12/2006
1	Lung Injury 11/2005
1	Hyperoxia 11/2004
1	Papilloma (Papillomatosis) 02/2002
1	Diarrhea 02/2002
1	Cholera 02/2002

Drug/Important Bio-Agent (IBA)

14	Interleukin-8 (Interleukin 8)IBA 12/2021 - 09/2003
13	ChemokinesIBA 12/2021 - 08/2002
10	CytokinesIBA 12/2021 - 12/2006
9	Bortezomib (Velcade)FDA Link 01/2018 - 09/2013
6	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 07/2008
5	Interleukin-10 (Interleukin 10)IBA 12/2016 - 09/2003
4	InterferonsIBA 01/2022 - 01/2020
4	Phosphotransferases (Kinase)IBA 01/2018 - 01/2014
4	Proteasome InhibitorsIBA 05/2015 - 07/2008
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 11/2016
3	Metformin (Glucophage)FDA LinkGeneric 10/2018 - 11/2016
3	Histone Deacetylase InhibitorsIBA 01/2018 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 02/2002
2	Messenger RNA (mRNA)IBA 11/2021 - 01/2014
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2017 - 09/2015
2	BAY 11-7085IBA 01/2017 - 09/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 12/2006
2	NF-kappa B (NF-kB)IBA 11/2004 - 02/2002
1	Histones (Histone)IBA 11/2021
1	AcidsIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Heme (Haem)IBA 01/2021
1	B7-H1 AntigenIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	romidepsin (FK228)FDA Link 01/2020
1	ChromatinIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2018
1	carfilzomibIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Vorinostat FDA Link 01/2017
1	AntigensIBA 01/2017
1	dimethylacetamideIBA 12/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2016
1	Malonyl Coenzyme A (Malonyl CoA)IBA 11/2016
1	Adenosine Monophosphate (AMP)IBA 11/2016
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 11/2016
1	RibonucleotidesIBA 11/2016
1	AMP-Activated Protein KinasesIBA 11/2016
1	Early Growth Response Protein 1IBA 01/2014
1	HMGB1 Protein (HMG1)IBA 01/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Chemotactic FactorsIBA 01/2014
1	AndrogensIBA 09/2013
1	Mono-SIBA 01/2013
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 01/2012
1	NF-KappaB Inhibitor alphaIBA 07/2008
1	Transcription Factors (Transcription Factor)IBA 03/2007
1	CurcuminIBA 11/2005
1	Caspase 3 (Caspase-3)IBA 11/2004
1	Annexin A5IBA 11/2004
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 09/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2002
1	magnesium citrateIBA 02/2002
1	ZincIBA 02/2002
1	ORALIT (ORS)IBA 02/2002
1	Phenolphthalein (Modane)IBA 02/2002
1	Cathartics (Purgatives)IBA 02/2002
1	I kappa B beta proteinIBA 02/2002

Therapy/Procedure

8	Therapeutics 10/2018 - 11/2005
1	Fluid Therapy (Oral Rehydration Therapy) 02/2002